PHOTOPHERESIS – Extracorporeal Photochemotherapy
Extracorporeal Photochemotherapy (ECP) has been recognised by the scientific community as a therapeutic option to treat various disorders, such as:
-Cutaneous T-cell lymphoma (Sezary syndrome) -GVHD (acute and chronic) -Organ transplant rejection -Autoimmune disorders

Macopharma has developed a complete product range for the off-line treatment of ECP: THERAFLEX – ECP.
Extracorporeal photochemotherapy (ECP) is based on the exposure of peripheral blood mononuclear cells to the photosensitizing agent (8-methoxypsoralen or 8-MOP) and UVA illumination.Mononuclear cells are harvested by cytapheresis and reinfused to the patient after cell illumination.